GPhA President Jaeger Has Experience In Legal, Regulatory Technicalities
This article was originally published in The Tan Sheet
Executive Summary
Generic Pharmaceutical Association President Kathleen Jaeger brings experience in legal and regulatory analysis to the trade association
You may also be interested in...
GPhA In Transition: Milanese Steps In As Hatch/Waxman Hill Debate Looms
A transition in the Generic Pharmaceutical Association's leadership comes as pressure for congressional action on Hatch/Waxman reform increases
FDA Review Standards “Inconsistent” For New Drugs, Generics, PhRMA Says
The lack of an integrated review staff for new drugs and generics has led to "inconsistent" review standards between new drug divisions and the Office of Generic Drugs, the Pharmaceutical Research & Manufacturers of America says in a "white paper" submitted to FDA
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC